Skip to main content
. 2022 Mar 27;14(4):720. doi: 10.3390/pharmaceutics14040720

Table 2.

Biodistribution (% injected dose) of 177Lu2O3-iFAP in CD1 mice at various time points (mean ± SD) (n = 3) after intravenous injection.

Organ Time (h)
3 48 72 96
Heart 0.13 ± 0.03 0.05 ± 0.03 0.01 ± 0.01 0.01 ± 0.01
Liver 24.98 ± 1.84 18.93 ± 2.04 17.23 ± 1.41 15.01 ± 1.17
Lung 0.35 ± 0.09 0.20 ± 0.11 0.14 ± 0.04 0.08 ± 0.03
Pancreas 0.10 ± 0.07 0.02 ± 0.01 0.00 ± 0.00 0.00 ± 0.00
Spleen 1.52 ± 0.39 1.14 ± 0.49 0.79 ± 0.39 0.75 ± 0.28
Kidney 0.98 ± 0.10 0.52 ± 0.07 0.21 ± 0.07 0.18 ± 0.08
Brain 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00